Nicotinamide riboside to protect the heart during breast cancer chemo
Treatments studied
Part of Cancer, Heart & circulation, Injuries & trauma, Skin clinical trials.
This trial tests whether nicotinamide riboside can help prevent heart problems caused by a common breast-cancer chemotherapy (anthracyclines). If you’re eligible, you’ll be followed to see how your heart is doing during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re a woman with stage IV (metastatic) breast cancer
- You are scheduled to receive chemotherapy that includes anthracyclines
- You can do most daily activities (performance status 0 to 2)
- Your expected life expectancy is at least 6 months
- You’re able to have heart MRI scans (CMR) as part of the study
- You have no allergy to nicotinamide riboside (Niagen) tablet
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests ribociclib, a targeted therapy, for women with hormone receptor-positive, HER2-negative breast cancer who still have cancer cells in the breast or lymph nodes after initial chemotherapy. It aims to reduce the chance of cancer coming back.
This study tests whether a natural supplement made from grape polyphenols can help protect the heart from damage caused by certain breast cancer chemotherapy drugs. It aims to see if taking this supplement alongside treatment can reduce the risk of heart problems.
This early-phase study tests a “neuromodulation” device (stimulating nerves that may affect the heart and blood vessels) to help lower cardiovascular risks after certain cancer chemotherapy. It may be most relevant if you recently had an anthracycline-based treatment and also have other heart-risk factors.
This study watches how chemotherapy and HER2-targeted drugs affect your heart during early-stage breast cancer treatment. Researchers use heart scans to catch any changes early and understand how to protect heart health.
This trial checks how well the heart handles anthracycline chemotherapy in breast cancer patients. It helps doctors find early signs of heart side effects so they can keep you safe during treatment.
This trial tests whether taking the cholesterol-lowering drug rosuvastatin can protect your heart from damage caused by a common type of chemotherapy called anthracyclines. It may help reduce the risk of heart problems during breast cancer treatment.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.